These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39094412)

  • 21. A framework for early-stage sustainability assessment of innovation projects enabled by weighted sum multi-criteria decision analysis in the presence of uncertainty.
    Henderson J; Peeling R
    Open Res Eur; 2024; 4():162. PubMed ID: 39381834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision support systems for environmental management: a case study on wastewater from agriculture.
    Massei G; Rocchi L; Paolotti L; Greco S; Boggia A
    J Environ Manage; 2014 Dec; 146():491-504. PubMed ID: 25217251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Choice-framework for Covid vaccines in India using a multi-criteria decision analysis approach.
    George TK; Nair NP; Singh AK; Dilesh Kumar A; Roy AD; Mohan VN; Kang G
    Vaccine; 2023 Jun; 41(25):3755-3762. PubMed ID: 37183072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid MCDA Methods to Integrate Multiple Ecosystem Services in Forest Management Planning: A Critical Review.
    Uhde B; Hahn WA; Griess VC; Knoke T
    Environ Manage; 2015 Aug; 56(2):373-88. PubMed ID: 25896820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework.
    Campolina AG; Estevez-Diz MDP; Abe JM; de Soárez PC
    PLoS One; 2022; 17(5):e0268584. PubMed ID: 35613115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A distance-based uncertainty analysis approach to multi-criteria decision analysis for water resource decision making.
    Hyde KM; Maier HR; Colby CB
    J Environ Manage; 2005 Dec; 77(4):278-90. PubMed ID: 16288957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of household connection to public network wastewater systems: regulatory impact assessment.
    de Carvalho BE; Costa SAB; Marques RC; Netto OC
    Water Sci Technol; 2019 Mar; 79(6):1060-1070. PubMed ID: 31070586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.
    Iskrov G; Miteva-Katrandzhieva T; Stefanov R
    Front Public Health; 2016; 4():214. PubMed ID: 27747207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
    Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
    Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From comparative risk assessment to multi-criteria decision analysis and adaptive management: recent developments and applications.
    Linkov I; Satterstrom FK; Kiker G; Batchelor C; Bridges T; Ferguson E
    Environ Int; 2006 Dec; 32(8):1072-93. PubMed ID: 16905190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indicator based multi-criteria decision support systems for wastewater treatment plants.
    Renfrew D; Vasilaki V; Katsou E
    Sci Total Environ; 2024 Mar; 915():169903. PubMed ID: 38199342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Prioritization Framework to Aid Healthcare Funding Decision Making in Health Technology Assessment in Australia: Application of Multicriteria Decision Analysis.
    Khanal S; Nghiem S; Miller M; Scuffham P; Byrnes J
    Value Health; 2024 Nov; 27(11):1585-1593. PubMed ID: 39094691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis.
    Broekhuizen H; IJzerman MJ; Hauber AB; Groothuis-Oudshoorn CGM
    Pharmacoeconomics; 2017 Mar; 35(3):259-269. PubMed ID: 27832461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Multicriteria Decision Analysis Algorithms in Food Safety: A Case Study on Emerging Zoonoses Prioritization.
    Garre A; Boué G; Fernández PS; Membré JM; Egea JA
    Risk Anal; 2020 Feb; 40(2):336-351. PubMed ID: 31469918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).
    Garau M; Hampson G; Devlin N; Mazzanti NA; Profico A
    Pharmacoecon Open; 2018 Jun; 2(2):153-163. PubMed ID: 29623625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prioritization of sediment management alternatives using stochastic multicriteria acceptability analysis.
    Alvarez-Guerra M; Canis L; Voulvoulis N; Viguri JR; Linkov I
    Sci Total Environ; 2010 Sep; 408(20):4354-67. PubMed ID: 20673964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA).
    Jiménez A; Ais A; Beaudet A; Gil A
    Orphanet J Rare Dis; 2018 Dec; 13(1):220. PubMed ID: 30526673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a Multi-Criteria Decision Analysis Tool to Support the Adoption of Evidence-Based Child Maltreatment Prevention Programs.
    Cruden G; Frerichs L; Powell BJ; Lanier P; Brown CH; Lich KH
    Prev Sci; 2020 Nov; 21(8):1059-1064. PubMed ID: 33040271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.
    Wagner M; Khoury H; Bennetts L; Berto P; Ehreth J; Badia X; Goetghebeur M
    BMC Cancer; 2017 Apr; 17(1):272. PubMed ID: 28412971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.